Cumberland Pharmaceuticals (CPIX) Earnings Analysis
Cumberland Pharmaceuticals (CPIX) has no confirmed upcoming earnings date. Last quarter (2026-03-03) it beat with EPS -0.01 USD vs -0.13 USD est (+92.3%). It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E -14.39.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CPIX next report earnings?
No confirmed upcoming earnings date is currently scheduled for CPIX. This page updates as the calendar is published.
CPIX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-03 | -0.01 USD | -0.13 USD | +92.3% | Beat |
| 2025-03-04 | -0.02 USD | -0.11 USD | +81.8% | Beat |
| 2024-11-07 | -0.02 USD | -0.13 USD | +84.6% | Beat |
Beat rate: 3/3 (100%) over reported quarters with consensus data.
CPIX valuation and analyst view
| Trailing P/E | -14.39 |
|---|---|
| Trailing EPS | -0.48339 USD |
| Price / book | 4.92 |
| Dividend yield | 0.00% |
| Market cap | 0.11B |
| Analyst consensus | Buy (3 buy / 2 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Cumberland Pharmaceuticals (CPIX)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for CPIX. This page updates as the calendar is published.
Did CPIX beat earnings last quarter?
In its 2026-03-03 report, CPIX posted EPS of -0.01 USD versus a -0.13 USD estimate — a beat of 92.3%.
What is CPIX's earnings track record?
Over the last 3 reported quarters with consensus data, CPIX beat estimates 3 times (100%).
What is CPIX's current P/E ratio and EPS?
CPIX trades at a trailing P/E of -14.39 on trailing EPS of -0.4833875326616404 USD.
What do analysts rate CPIX?
Analyst consensus is "Buy" across 5 ratings (0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell).